The GreenWave Buzz

August 5, 2020 This week, the State of Colorado released its medical marijuana cardholder statistics for May and June. The average number of cardholders declined from ~86K in H1:19 to ~82K in H1:20 while the average patient $ spend/month increased to $400 from $313...

The complexities of the U.S. cannabis industry have been exacerbated by the consequences of states operating within the confines of closed economies defined by their own interpretations of legitimacy under the shadow of existing federal laws. These variations of...

Many cannabis businesses are struggling, though not all the blame resides in faulty management decisions. In this edition of “The GreenWave Buzz,” we highlight the added costs of federal prohibition and discuss other risk factors that may cause near term volatility for both public and private valuations, giving particular attention to the tax burden associated with Section 280E of the IRS code.

Welcome to “The GreenWave Buzz”, a periodic briefing intended to provide insights and analysis of various subject matters and business trends effecting the emerging cannabis industry. In this issue, we revisit our initial industry thesis and expectations from 2014,...

The announcement by AG Jeff Sessions to rescind the Obama Administration’s guidance on Marijuana business activities (Cole Memorandum) causes a certain near term concern for investment and growth potentials within the Cannabis industry. Although the Federal Government...

When investors contemplate capital shifts into the cannabis sector there remains the risk obstacle of the federal government’s intransigent position of classifying marijuana as a schedule I drug, having no medical value and having high potential for abuse. By lumping...